Ratings iX Biopharma Ltd.

Equities

42C

SG1BD9000009

Market Closed - Singapore S.E. 09:27:15 2024-03-27 pm EDT 5-day change 1st Jan Change
0.052 SGD -1.89% Intraday chart for iX Biopharma Ltd. +13.04% +15.56%

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
+15.56% 29.61M - -
+33.46% 701B
C+
+26.24% 570B
B
+0.93% 381B
C+
+21.03% 334B
B-
+17.51% 322B
C+
+2.95% 212B
B-
+0.74% 209B
B+
-6.05% 205B
A+
-3.61% 157B
C+
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
-
Earnings Growth
-
EBITDA / Sales
-
Profitability
-
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
-
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes